Evidence map›Paper›PMID 30004447›Full record

ArticleGenes2018

SEGF: A Novel Method for Gene Fusion Detection from Single-End Next-Generation Sequencing Data.

Hai Xu, Xiaojin Wu, Dawei Sun, Shijun Li, Siwen Zhang, Miao Teng, Jianlong Bu, Xizhe Zhang, Bo Meng, Weitao Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Hai XuDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin 150049, China. xuhai18245159059@163.com.
Xiaojin WuDepartment of Radiation Oncology, The First People's Hospital of Xuzhou, Xuzhou 221002, China. Xiaojin.w@hotmail.com.
Dawei SunDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin 150049, China. dawei.sun@163.com.
Shijun LiDepartment of Pathology, Chifeng Municiple Hospital, Chifeng 024000, China. cflishijun6588@sina.com.
Siwen ZhangGeneis Beijing Co., Ltd., Beijing 100102, China. zhangsw@geneis.cn.
Miao TengGeneis Beijing Co., Ltd., Beijing 100102, China. miao.teng@foxmail.com.
Jianlong BuDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin 150049, China. bjl_1987@163.com.
Xizhe ZhangDepartment of Anesthesiology, Chifeng Municiple Hospital, Chifeng 024000, China. zhangxizhe1965@sina.com.
Bo MengGeneis Beijing Co., Ltd., Beijing 100102, China. mengb@geneis.cn.
Weitao WangGeneis Beijing Co., Ltd., Beijing 100102, China. wangwt@geneis.cn.
Geng TianGeneis Beijing Co., Ltd., Beijing 100102, China. tiang@geneis.cn.
Huixin LinGeneis Beijing Co., Ltd., Beijing 100102, China. linhx@geneis.cn.
Dawei YuanGeneis Beijing Co., Ltd., Beijing 100102, China. yuandw-sci@geneis.cn.
Jidong LangGeneis Beijing Co., Ltd., Beijing 100102, China. langjd@geneis.cn.ORCID 0000-0003-1573-4114
Shidong XuDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin 150049, China. xusd163@163.com.
Cipher Gene (China) · CNHarbin Medical University · CNChifeng Municipal Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the development and application of next-generation sequencing (NGS) and target capture technology, the demand for an effective analysis method to accurately detect gene fusion from high-throughput data is growing. Hence, we developed a novel fusion gene analyzing method called single-end gene fusion (SEGF) by starting with single-end DNA-seq data. This approach takes raw sequencing data as input, and integrates the commonly used alignment approach basic local alignment search tool (BLAST) and short oligonucleotide analysis package (SOAP) with stringent passing filters to achieve successful fusion gene detection. To evaluate SEGF, we compared it with four other fusion gene discovery analysis methods by analyzing sequencing results of 23 standard DNA samples and DNA extracted from 286 lung cancer formalin fixed paraffin embedded (FFPE) samples. The results generated by SEGF indicated that it not only detected the fusion genes from standard samples and clinical samples, but also had the highest accuracy and sensitivity among the five compared methods. In addition, SEGF was capable of detecting complex gene fusion types from single-end NGS sequencing data compared with other methods. By using SEGF to acquire gene fusion information at DNA level, more useful information can be retrieved from the DNA panel or other DNA sequencing methods without generating RNA sequencing information to benefit clinical diagnosis or medication instruction. It was a timely and cost-effective measure with regard to research or diagnosis. Considering all the above, SEGF is a straightforward method without manipulating complicated arguments, providing a useful approach for the precise detection of gene fusion variation.

Indexed as

fusion detectionsingle-end gene fusionsingle-end next-generation sequencing data

Identifiers

PMID30004447
PMCPMC6070977
OpenAlexW2809895814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.